id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT01990209 | 12:33:chronic_disease,56:78:chronic_disease,,,213:234:chronic_disease,240:260:chronic_disease,262:280:chronic_disease,297:319:chronic_disease,335:352:chronic_disease,358:405:chronic_disease,,446:456:treatment | History of myocardial infarction, unstable symptomatic ischemic heart disease, ongoing arrhythmias > Grade 2 (National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE], Version 4.0), thromboembolic events (eg, deep vein thrombosis, pulmonary embolism, or symptomatic cerebrovascular events),... | 3 | [
"History",
"of",
"myocardial",
"infarction",
",",
"unstable",
"symptomatic",
"ischemic",
"heart",
"disease",
",",
"ongoing",
"arrhythmias",
">",
"Grade",
"2",
"(",
"National",
"Cancer",
"Institute",
"[",
"NCI",
"]",
"Common",
"Terminology",
"Criteria",
"for",
"A... | [
0,
0,
2,
2,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2... |
NCT02342782 | 31:49:treatment,59:63:cancer,137:174:cancer,179:183:cancer | First remission after initial first-line therapy (CR1) in PTCL patients, except for anaplastic lymphoma receptor tyrosine kinase (ALK)+ anaplastic large cell lymphoma (ALCL) and CTCL | 3 | [
"First",
"remission",
"after",
"initial",
"first-line",
"therapy",
"(",
"CR1",
")",
"in",
"PTCL",
"patients",
",",
"except",
"for",
"anaplastic",
"lymphoma",
"receptor",
"tyrosine",
"kinase",
"(",
"ALK",
")",
"+",
"anaplastic",
"large",
"cell",
"lymphoma",
"("... | [
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
3,
0,
0,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT02108860 | 7:16:chronic_disease,22:56:chronic_disease,58:69:chronic_disease,85:96:chronic_disease | Known infection with human immunodeficiency virus (HIV), hepatitis C, or a positive hepatitis B surface antigen | 3 | [
"Known",
"infection",
"with",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
",",
"hepatitis",
"C",
",",
"or",
"a",
"positive",
"hepatitis",
"B",
"surface",
"antigen"
] | [
0,
2,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01684904 | 12:23:treatment,, | the use of transfusion or other intervention to achieve Hgb ≥ 8.0 is acceptable | 3 | [
"the",
"use",
"of",
"transfusion",
"or",
"other",
"intervention",
"to",
"achieve",
"Hgb",
"≥",
"8.0",
"is",
"acceptable"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02091141 | 13:35:chronic_disease,,72:87:chronic_disease,,111:132:chronic_disease,137:161:chronic_disease,,207:216:treatment,218:237:chronic_disease,242:257:chronic_disease | Significant cardiovascular disease, such as New York Heart Association cardiac disease (Class II or greater), myocardial infarction, or cerebrovascular accident within 3 months prior to initiation of study treatment, unstable arrhythmia, or unstable angina | 3 | [
"Significant",
"cardiovascular",
"disease",
",",
"such",
"as",
"New",
"York",
"Heart",
"Association",
"cardiac",
"disease",
"(",
"Class",
"II",
"or",
"greater",
")",
",",
"myocardial",
"infarction",
",",
"or",
"cerebrovascular",
"accident",
"within",
"3",
"month... | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
2,
2,
0,
0,
0,
0
] |
NCT00368355 | 35:64:chronic_disease,, | Patients with pre-existing severe restrictive pulmonary disease (FVC less than 40% of predicted) | 3 | [
"Patients",
"with",
"pre-existing",
"severe",
"restrictive",
"pulmonary",
"disease",
"(",
"FVC",
"less",
"than",
"40",
"%",
"of",
"predicted",
")"
] | [
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02430051 | 13:29:chronic_disease | Significant motor impairment | 3 | [
"Significant",
"motor",
"impairment"
] | [
0,
2,
2
] |
NCT02513797 | 34:67:treatment,76:96:treatment,98:118:treatment,122:154:treatment | Documented presence of implanted congenital defect closure devices, (e.g., atrial septal defect, patent foramen ovale or ventricular septal defect device) | 3 | [
"Documented",
"presence",
"of",
"implanted",
"congenital",
"defect",
"closure",
"devices",
",",
"(",
"e.g.",
",",
"atrial",
"septal",
"defect",
",",
"patent",
"foramen",
"ovale",
"or",
"ventricular",
"septal",
"defect",
"device",
")"
] | [
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
1,
1,
1,
0,
1,
1,
1,
0,
1,
1,
1,
1,
0
] |
NCT02811679 | 32:45:chronic_disease,54:62:chronic_disease,64:71:chronic_disease,73:80:chronic_disease,81:88:chronic_disease,90:99:chronic_disease,101:122:chronic_disease,124:142:chronic_disease,144:166:chronic_disease,168:177:chronic_disease | History of or current relevant CNS pathology such as epilepsy, seizure, paresis,aphasia, apoplexia, severe brain injuries, cerebellar disease, organic brain syndrome, psychosis | 3 | [
"History",
"of",
"or",
"current",
"relevant",
"CNS",
"pathology",
"such",
"as",
"epilepsy",
",",
"seizure",
",",
"paresis",
",",
"aphasia",
",",
"apoplexia",
",",
"severe",
"brain",
"injuries",
",",
"cerebellar",
"disease",
",",
"organic",
"brain",
"syndrome",... | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
0,
2,
0,
2,
0,
2,
0,
2,
0,
2,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
2
] |
NCT02344355 | 14:34:chronic_disease,77:93:chronic_disease,143:152:treatment,166:190:chronic_disease,192:216:chronic_disease,218:236:chronic_disease,241:260:chronic_disease | Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection that would result in a hospital stay or delay of treatment, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study req... | 3 | [
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"ongoing",
"or",
"active",
"infection",
"that",
"would",
"result",
"in",
"a",
"hospital",
"stay",
"or",
"delay",
"of",
"treatment",
",",
"symptomatic",
"congestive",... | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02484404 | 23:32:treatment,23:47:treatment,69:114:cancer | Patients who have had treatment with docetaxel for the treatment of metastatic castrate-sensitive prostate cancer | 3 | [
"Patients",
"who",
"have",
"had",
"treatment",
"with",
"docetaxel",
"for",
"the",
"treatment",
"of",
"metastatic",
"castrate-sensitive",
"prostate",
"cancer"
] | [
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
3,
3,
3,
3
] |
NCT02460835 | 21:42:treatment | contraindication to contrast-enhanced MRI | 3 | [
"contraindication",
"to",
"contrast-enhanced",
"MRI"
] | [
0,
0,
1,
1
] |
NCT03104725 | 18:21:allergy_name | Known allergy to NAC | 3 | [
"Known",
"allergy",
"to",
"NAC"
] | [
0,
0,
0,
4
] |
NCT02166905 | 38:56:cancer,58:72:cancer,85:105:cancer,112:124:treatment,156:180:cancer | Eligible patients will be women with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma after chemotherapy with no evidence of disease or minimal residual disease for primary or recurrent disease; this may or may not be measurable; these patients would normally enter a period of observation after stand... | 3 | [
"Eligible",
"patients",
"will",
"be",
"women",
"with",
"epithelial",
"ovarian",
",",
"fallopian",
"tube",
",",
"or",
"primary",
"peritoneal",
"carcinoma",
"after",
"chemotherapy",
"with",
"no",
"evidence",
"of",
"disease",
"or",
"minimal",
"residual",
"disease",
... | [
0,
0,
0,
0,
0,
0,
3,
3,
0,
3,
3,
0,
0,
0,
3,
3,
0,
1,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02476786 | 7:10:chronic_disease,37:59:treatment,123:142:treatment | Known HIV-positivity on combination antiretroviral therapy because of the potential for pharmacokinetic interactions with endocrine therapies | 3 | [
"Known",
"HIV-positivity",
"on",
"combination",
"antiretroviral",
"therapy",
"because",
"of",
"the",
"potential",
"for",
"pharmacokinetic",
"interactions",
"with",
"endocrine",
"therapies"
] | [
0,
2,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02159560 | 17:35:treatment, | Expected use of epidural analgesia for >24 hours | 3 | [
"Expected",
"use",
"of",
"epidural",
"analgesia",
"for",
">",
"24",
"hours"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT02433158 | 25:28:chronic_disease | Documented diagnosis of SCD | 3 | [
"Documented",
"diagnosis",
"of",
"SCD"
] | [
0,
0,
0,
2
] |
NCT03113695 | 1:14:treatment, | Major surgery within 4 weeks prior to the start of treatment | 3 | [
"Major",
"surgery",
"within",
"4",
"weeks",
"prior",
"to",
"the",
"start",
"of",
"treatment"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02442323 | 1:15:cancer | adenocarcinoma subtypes | 3 | [
"adenocarcinoma",
"subtypes"
] | [
3,
0
] |
NCT03042689 | 11:17:chronic_disease, | new-onset angina within 3 months before randomization | 3 | [
"new-onset",
"angina",
"within",
"3",
"months",
"before",
"randomization"
] | [
0,
2,
0,
0,
0,
0,
0
] |
NCT02131389 | 4:9:chronic_disease,, | Is Obese: (Defined for this study as having a BMI>45) | 3 | [
"Is",
"Obese",
":",
"(",
"Defined",
"for",
"this",
"study",
"as",
"having",
"a",
"BMI",
">",
"45",
")"
] | [
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02326818 | 11:37:treatment | Receiving botulinum toxin injections under 85-N-0195 | 3 | [
"Receiving",
"botulinum",
"toxin",
"injections",
"under",
"85-N-0195"
] | [
0,
1,
1,
1,
0,
0
] |
NCT02531295 | 31:45:chronic_disease | Screening TSH consistent with hypothyroidism | 3 | [
"Screening",
"TSH",
"consistent",
"with",
"hypothyroidism"
] | [
0,
0,
0,
0,
2
] |
NCT02498951 | 68:88:cancer | Clinical evidence of extra-central nervous system (CNS) (systemic) non-Hodgkin lymphoma | 3 | [
"Clinical",
"evidence",
"of",
"extra-central",
"nervous",
"system",
"(",
"CNS",
")",
"(",
"systemic",
")",
"non-Hodgkin",
"lymphoma"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT01720836 | 62:95:cancer | Subjects must have histologically or cytologically confirmed non-small cell lung cancer (NSCLC | 3 | [
"Subjects",
"must",
"have",
"histologically",
"or",
"cytologically",
"confirmed",
"non-small",
"cell",
"lung",
"cancer",
"(",
"NSCLC"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
0
] |
NCT02047721 | 12:40:chronic_disease,42:59:chronic_disease,61:86:chronic_disease,98:113:chronic_disease,115:128:chronic_disease,130:145:chronic_disease | history of cardiovascular disease (CVD), diabetes mellitus, uncontrolled hypertension, untreated thyroid disease, renal disease, hepatic disease, or any other medical condition affecting weight or energy metabolism | 3 | [
"history",
"of",
"cardiovascular",
"disease",
"(",
"CVD",
")",
",",
"diabetes",
"mellitus",
",",
"uncontrolled",
"hypertension",
",",
"untreated",
"thyroid",
"disease",
",",
"renal",
"disease",
",",
"hepatic",
"disease",
",",
"or",
"any",
"other",
"medical",
"... | [
0,
0,
2,
2,
2,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02582827 | 98:126:treatment,165:198:treatment,200:245:treatment,250:273:treatment, | Transfusion of blood products [red blood cells (RBC), white blood cells (WBC) or whole blood] or Hematopoietic growth factors or other hematologic support, such as erythropoiesis-stimulating agents, granulocyte-colony stimulating factor (G-CSF), or platelet transfusion(s) within 14 days of screening | 3 | [
"Transfusion",
"of",
"blood",
"products",
"[",
"red",
"blood",
"cells",
"(",
"RBC",
")",
",",
"white",
"blood",
"cells",
"(",
"WBC",
")",
"or",
"whole",
"blood",
"]",
"or",
"Hematopoietic",
"growth",
"factors",
"or",
"other",
"hematologic",
"support",
",",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02430077 | 36:39:allergy_name | Hypersensitivity or intolerance to OCA or any components of its formulation | 3 | [
"Hypersensitivity",
"or",
"intolerance",
"to",
"OCA",
"or",
"any",
"components",
"of",
"its",
"formulation"
] | [
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0
] |
NCT02798458 | 12:26:chronic_disease,28:50:chronic_disease,62:83:chronic_disease | History of diverticulitis, diverticular stricture, and other intestinal strictures | 3 | [
"History",
"of",
"diverticulitis",
",",
"diverticular",
"stricture",
",",
"and",
"other",
"intestinal",
"strictures"
] | [
0,
0,
2,
0,
2,
2,
0,
0,
0,
2,
2
] |
NCT02152995 | 14:34:chronic_disease,77:93:chronic_disease,107:131:chronic_disease,142:157:chronic_disease,167:177:chronic_disease,182:201:chronic_disease | Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements | 3 | [
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"ongoing",
"or",
"active",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",... | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
2,
2,
0,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01941316 | 18:31:treatment, | Must have had no major surgery within 28 days prior to enrollment | 3 | [
"Must",
"have",
"had",
"no",
"major",
"surgery",
"within",
"28",
"days",
"prior",
"to",
"enrollment"
] | [
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01508390 | 23:53:cancer | Histologically proven adenocarcinoma of the prostate | 3 | [
"Histologically",
"proven",
"adenocarcinoma",
"of",
"the",
"prostate"
] | [
0,
0,
3,
3,
3,
3
] |
NCT02120222 | 1:27:chronic_disease | inflammatory bowel disease | 3 | [
"inflammatory",
"bowel",
"disease"
] | [
2,
2,
2
] |
NCT02577549 | 120:129:chronic_disease,131:146:chronic_disease,155:178:chronic_disease | Significant co-morbid disease that would threaten safety or impair ability to participate in interventions or testing (Blindness; Type 1 diabetes; Severe coronary artery disease) | 3 | [
"Significant",
"co-morbid",
"disease",
"that",
"would",
"threaten",
"safety",
"or",
"impair",
"ability",
"to",
"participate",
"in",
"interventions",
"or",
"testing",
"(",
"Blindness",
";",
"Type",
"1",
"diabetes",
";",
"Severe",
"coronary",
"artery",
"disease",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2,
0,
0,
2,
2,
2,
0
] |
NCT03043794 | 102:116:treatment | Subjects without placement of a biopsy clip at the diagnostic procedure who are unwilling to undergo clip placement | 3 | [
"Subjects",
"without",
"placement",
"of",
"a",
"biopsy",
"clip",
"at",
"the",
"diagnostic",
"procedure",
"who",
"are",
"unwilling",
"to",
"undergo",
"clip",
"placement"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01616108 | 8:21:chronic_disease | Active eye infection | 3 | [
"Active",
"eye",
"infection"
] | [
0,
2,
2
] |
NCT02531880 | 21:56:chronic_disease | Personal history of Parkinson s Disease or Parkinsonism or presence of this disease in a 1st degree relative | 3 | [
"Personal",
"history",
"of",
"Parkinson",
"s",
"Disease",
"or",
"Parkinsonism",
"or",
"presence",
"of",
"this",
"disease",
"in",
"a",
"1st",
"degree",
"relative"
] | [
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01547429 | 84:92:chronic_disease,94:108:treatment,117:129:chronic_disease,131:146:chronic_disease,170:184:chronic_disease | Abnormality of the iris or ocular structure which would preclude fixation, such as aniridia, hemiiridectomy, severe iris atrophy, rubeosis iridis, or other compromising iris pathology | 3 | [
"Abnormality",
"of",
"the",
"iris",
"or",
"ocular",
"structure",
"which",
"would",
"preclude",
"fixation",
",",
"such",
"as",
"aniridia",
",",
"hemiiridectomy",
",",
"severe",
"iris",
"atrophy",
",",
"rubeosis",
"iridis",
",",
"or",
"other",
"compromising",
"i... | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
1,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02496611 | 1:27:treatment | Previous bariatric surgery | 3 | [
"Previous",
"bariatric",
"surgery"
] | [
1,
1,
1
] |
NCT03105362 | 20:34:treatment, | Patients receiving IV antibiotics within the previous 72h | 3 | [
"Patients",
"receiving",
"IV",
"antibiotics",
"within",
"the",
"previous",
"72h"
] | [
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT02968602 | ,22:31:treatment,35:57:treatment,,96:109:treatment,111:126:treatment,128:144:treatment,146:169:treatment | Less than two months treatment of adjunctive medications AND less than one month on same dose: beta blockers, antidepressants, mood stabilizers, antianxiety medications | 3 | [
"Less",
"than",
"two",
"months",
"treatment",
"of",
"adjunctive",
"medications",
"AND",
"less",
"than",
"one",
"month",
"on",
"same",
"dose",
":",
"beta",
"blockers",
",",
"antidepressants",
",",
"mood",
"stabilizers",
",",
"antianxiety",
"medications"
] | [
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
1,
0,
1,
1
] |
NCT02665338 | 12:22:chronic_disease | History of autoimmune | 3 | [
"History",
"of",
"autoimmune"
] | [
0,
0,
2
] |
NCT03104699 | 48:74:cancer | Subjects must have recurrent, unresectable, or metastatic cervical cancer | 3 | [
"Subjects",
"must",
"have",
"recurrent",
",",
"unresectable",
",",
"or",
"metastatic",
"cervical",
"cancer"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3
] |
NCT01697865 | 10:28:chronic_disease | Previous shoulder infection | 3 | [
"Previous",
"shoulder",
"infection"
] | [
0,
2,
2
] |
NCT02250157 | 31:42:treatment,60:69:treatment,79:89:cancer | Are currently receiving other medications intended for the treatment of their malignancy | 3 | [
"Are",
"currently",
"receiving",
"other",
"medications",
"intended",
"for",
"the",
"treatment",
"of",
"their",
"malignancy"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
1,
0,
0,
3
] |
NCT01942018 | 1:33:treatment | Prior esophageal Botox injection | 3 | [
"Prior",
"esophageal",
"Botox",
"injection"
] | [
1,
1,
1,
1
] |
NCT02549833 | 41:49:treatment,74:93:treatment,113:128:cancer | must show supratentorial, non-enhancing T2-FLAIR lesions that need to be surgically resected and are likely WHO grade II glioma | 3 | [
"must",
"show",
"supratentorial",
",",
"non-enhancing",
"T2-FLAIR",
"lesions",
"that",
"need",
"to",
"be",
"surgically",
"resected",
"and",
"are",
"likely",
"WHO",
"grade",
"II",
"glioma"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
3,
3,
3
] |
NCT02189889 | 32:40:allergy_name | have known hypersensitivity to Feraheme or any of its components | 3 | [
"have",
"known",
"hypersensitivity",
"to",
"Feraheme",
"or",
"any",
"of",
"its",
"components"
] | [
0,
0,
0,
0,
4,
0,
0,
0,
0,
0
] |
NCT03122912 | 1:7:treatment, | Lovaza™ (prescription fish oil) and not willing to go off Lovaza for 3 weeks prior to enrollment to end of study | 3 | [
"Lovaza™",
"(",
"prescription",
"fish",
"oil",
")",
"and",
"not",
"willing",
"to",
"go",
"off",
"Lovaza",
"for",
"3",
"weeks",
"prior",
"to",
"enrollment",
"to",
"end",
"of",
"study"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02519322 | 52:71:allergy_name | History of severe hypersensitivity reaction to any monoclonal antibody | 3 | [
"History",
"of",
"severe",
"hypersensitivity",
"reaction",
"to",
"any",
"monoclonal",
"antibody"
] | [
0,
0,
0,
0,
0,
0,
0,
4,
4
] |
NCT02271919 | 19:33:chronic_disease,40:47:chronic_disease,51:71:chronic_disease,,,122:135:chronic_disease,, | History of severe kidney disease (e.g. chronic or acute kidney failure) with creatinine clearance below 30 and/or severe liver disease with liver tests over 4 times the upper normal level | 3 | [
"History",
"of",
"severe",
"kidney",
"disease",
"(",
"e.g",
".",
"chronic",
"or",
"acute",
"kidney",
"failure",
")",
"with",
"creatinine",
"clearance",
"below",
"30",
"and/or",
"severe",
"liver",
"disease",
"with",
"liver",
"tests",
"over",
"4",
"times",
"th... | [
0,
0,
0,
2,
2,
0,
0,
0,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02562235 | 1:33:chronic_disease | Pulmonary veno-occlusive disease | 3 | [
"Pulmonary",
"veno-occlusive",
"disease"
] | [
2,
2,
2
] |
NCT02503709 | 1:35:chronic_disease,31:34:chronic_disease,57:91:treatment,115:129:treatment,, | Human immunodeficiency virus (HIV)-positive patients on combination antiretroviral therapy known to interact with CYP isoenzymes are ineligible; in addition, HIV patients with CD4 count < 200 cells/uL are ineligible; appropriate studies will be undertaken in patients receiving combination antiretroviral therapy when in... | 3 | [
"Human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"-positive",
"patients",
"on",
"combination",
"antiretroviral",
"therapy",
"known",
"to",
"interact",
"with",
"CYP",
"isoenzymes",
"are",
"ineligible",
";",
"in",
"addition",
",",
"HIV",
"patients",
"with",
... | [
2,
2,
2,
2,
2,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03011567 | 29:44:treatment,80:99:treatment,103:125:chronic_disease | Use of therapeutic doses of anticoagulation (low dose anticoagulation used for routine prophylaxis of venous thromboembolism is acceptable) | 3 | [
"Use",
"of",
"therapeutic",
"doses",
"of",
"anticoagulation",
"(",
"low",
"dose",
"anticoagulation",
"used",
"for",
"routine",
"prophylaxis",
"of",
"venous",
"thromboembolism",
"is",
"acceptable",
")"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
2,
2,
0,
0,
0
] |
NCT02544880 | 14:25:chronic_disease | Uncontrolled arrhythmias | 3 | [
"Uncontrolled",
"arrhythmias"
] | [
0,
2
] |
NCT01620216 | 11:38:chronic_disease | Diagnosed congenital long QT syndrome | 3 | [
"Diagnosed",
"congenital",
"long",
"QT",
"syndrome"
] | [
0,
2,
2,
2,
2
] |
NCT03013543 | 1:37:chronic_disease | LEPR Heterozygous Deficiency Obesity | 3 | [
"LEPR",
"Heterozygous",
"Deficiency",
"Obesity"
] | [
2,
2,
2,
2
] |
NCT02050113 | 4:12:chronic_disease,16:31:chronic_disease,62:90:chronic_disease | No systemic or local infection that may increase the risk of endovascular graft infection | 3 | [
"No",
"systemic",
"or",
"local",
"infection",
"that",
"may",
"increase",
"the",
"risk",
"of",
"endovascular",
"graft",
"infection"
] | [
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02444689 | 15:20:chronic_disease | Overweight or Obese | 3 | [
"Overweight",
"or",
"Obese"
] | [
0,
0,
2
] |
NCT02542202 | 35:62:treatment,66:94:treatment,102:119:treatment | Patients may not be receiving any systemic anti-cancer agents or other investigational agents during radiation therapy | 3 | [
"Patients",
"may",
"not",
"be",
"receiving",
"any",
"systemic",
"anti-cancer",
"agents",
"or",
"other",
"investigational",
"agents",
"during",
"radiation",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
1,
1,
0,
1,
1
] |
NCT02568267 | 7:24:chronic_disease | Known active infections | 3 | [
"Known",
"active",
"infections"
] | [
0,
2,
2
] |
NCT02498613 | 22:29:chronic_disease,31:54:chronic_disease,59:87:chronic_disease, | History of abdominal fistula, intra-abdominal abscess, or gastrointestinal perforation within the 3 months prior to enrollment | 3 | [
"History",
"of",
"abdominal",
"fistula",
",",
"intra-abdominal",
"abscess",
",",
"or",
"gastrointestinal",
"perforation",
"within",
"the",
"3",
"months",
"prior",
"to",
"enrollment"
] | [
0,
0,
0,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT03125902 | 5:8:chronic_disease, | The HBV DNA test will be performed only for patients who have a positive HBcAb test | 3 | [
"The",
"HBV",
"DNA",
"test",
"will",
"be",
"performed",
"only",
"for",
"patients",
"who",
"have",
"a",
"positive",
"HBcAb",
"test"
] | [
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02418195 | 23:40:treatment | capable of undergoing ketamine infusion | 3 | [
"capable",
"of",
"undergoing",
"ketamine",
"infusion"
] | [
0,
0,
0,
1,
1
] |
NCT02236013 | ,,124:134:treatment | Female subject must not donate ova starting at Screening and throughout the study period, and for 180 days after the final study drug administration | 3 | [
"Female",
"subject",
"must",
"not",
"donate",
"ova",
"starting",
"at",
"Screening",
"and",
"throughout",
"the",
"study",
"period",
",",
"and",
"for",
"180",
"days",
"after",
"the",
"final",
"study",
"drug",
"administration"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02642939 | 27:40:treatment, | Patients who have had any major surgery within 4 weeks prior to day 1 of cycle 1 | 3 | [
"Patients",
"who",
"have",
"had",
"any",
"major",
"surgery",
"within",
"4",
"weeks",
"prior",
"to",
"day",
"1",
"of",
"cycle",
"1"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03181516 | 1:20:treatment | Keflex (cephalexin) | 3 | [
"Keflex",
"(",
"cephalexin",
")"
] | [
1,
1,
0,
0
] |
NCT01620216 | 1:26:chronic_disease | Uncontrolled hypertension | 3 | [
"Uncontrolled",
"hypertension"
] | [
2,
2
] |
NCT02943408 | 17:53:chronic_disease | Other Specified Trauma and Stressor-Related Disorder (309.89) | 3 | [
"Other",
"Specified",
"Trauma",
"and",
"Stressor-Related",
"Disorder",
"(",
"309.89",
")"
] | [
0,
0,
2,
2,
2,
2,
0,
0,
0
] |
NCT02400255 | ,60:67:treatment,,,108:129:treatment,,,165:185:treatment, | Adequate engraftment within 7 days prior to starting study therapy: ANC ≥ 1.0 x 109/L without daily use of myeloid growth factor; and platelet ≥ 25 x 109/L without platelet transfusion within 1 week | 3 | [
"Adequate",
"engraftment",
"within",
"7",
"days",
"prior",
"to",
"starting",
"study",
"therapy",
":",
"ANC",
"≥",
"1.0",
"x",
"109/L",
"without",
"daily",
"use",
"of",
"myeloid",
"growth",
"factor",
";",
"and",
"platelet",
"≥",
"25",
"x",
"109/L",
"without... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01969643 | 1:22:cancer | Malignant CNS disease that has not been definitively treated | 3 | [
"Malignant",
"CNS",
"disease",
"that",
"has",
"not",
"been",
"definitively",
"treated"
] | [
3,
3,
3,
0,
0,
0,
0,
0,
0
] |
NCT01850758 | 23:26:treatment | Contraindications for MRI | 3 | [
"Contraindications",
"for",
"MRI"
] | [
0,
0,
1
] |
NCT02518594 | 12:18:chronic_disease | History of herpes | 3 | [
"History",
"of",
"herpes"
] | [
0,
0,
2
] |
NCT03135522 | 1:25:chronic_disease | Congestive heart failure | 3 | [
"Congestive",
"heart",
"failure"
] | [
2,
2,
2
] |
NCT02724540 | 1:12:cancer,, | liver tumor burden less than or equal to 70% of the total liver volume by visual estimate | 3 | [
"liver",
"tumor",
"burden",
"less",
"than",
"or",
"equal",
"to",
"70",
"%",
"of",
"the",
"total",
"liver",
"volume",
"by",
"visual",
"estimate"
] | [
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02215096 | 13:48:treatment,59:79:treatment,,153:162:treatment | Presence of hepatitis B surface antigen (HBsAg), positive hepatitis C antibody test result at screening or within 3 months prior to first dose of study treatment | 3 | [
"Presence",
"of",
"hepatitis",
"B",
"surface",
"antigen",
"(",
"HBsAg",
")",
",",
"positive",
"hepatitis",
"C",
"antibody",
"test",
"result",
"at",
"screening",
"or",
"within",
"3",
"months",
"prior",
"to",
"first",
"dose",
"of",
"study",
"treatment"
] | [
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01595529 | 1:11:treatment | Cephalexin | 3 | [
"Cephalexin"
] | [
1
] |
NCT02759120 | 1:30:treatment,36:48:treatment,50:63:treatment,65:81:treatment,86:98:treatment | Concomitant immunosuppression with azathioprine, mycophenolate, cyclophosphamide, or cyclosporine | 3 | [
"Concomitant",
"immunosuppression",
"with",
"azathioprine",
",",
"mycophenolate",
",",
"cyclophosphamide",
",",
"or",
"cyclosporine"
] | [
1,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1
] |
NCT01604512 | 22:29:allergy_name | allergic reaction to Gd-DTPA | 3 | [
"allergic",
"reaction",
"to",
"Gd-DTPA"
] | [
0,
0,
0,
4
] |
NCT01532687 | 48:79:cancer,102:119:cancer,145:159:cancer | subjects with a history of completely resected non-melanomatous skin carcinoma, successfully treated in situ carcinoma, or successfully treated bladder cancer are eligible | 3 | [
"subjects",
"with",
"a",
"history",
"of",
"completely",
"resected",
"non-melanomatous",
"skin",
"carcinoma",
",",
"successfully",
"treated",
"in",
"situ",
"carcinoma",
",",
"or",
"successfully",
"treated",
"bladder",
"cancer",
"are",
"eligible"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
3,
3,
0,
0
] |
NCT01366612 | 14:20:chronic_disease | uncontrolled angina | 3 | [
"uncontrolled",
"angina"
] | [
0,
2
] |
NCT02637947 | 19:40:chronic_disease | subject has had a myocardial infarction | 3 | [
"subject",
"has",
"had",
"a",
"myocardial",
"infarction"
] | [
0,
0,
0,
0,
2,
2
] |
NCT02163317 | ,,49:64:treatment | PSA should not be obtained within 10 days after prostate biopsy | 3 | [
"PSA",
"should",
"not",
"be",
"obtained",
"within",
"10",
"days",
"after",
"prostate",
"biopsy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03123068 | 1:27:treatment,,60:72:treatment,76:88:treatment | Immune-suppressant therapy within the last 2 months (e.g., azathioprine or cyclosporine) | 3 | [
"Immune-suppressant",
"therapy",
"within",
"the",
"last",
"2",
"months",
"(",
"e.g.",
",",
"azathioprine",
"or",
"cyclosporine",
")"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0
] |
NCT02819635 | 14:32:chronic_disease, | Diagnosis of ulcerative colitis for 90 days or greater prior to Baseline, confirmed by colonoscopy during the Screening Period | 3 | [
"Diagnosis",
"of",
"ulcerative",
"colitis",
"for",
"90",
"days",
"or",
"greater",
"prior",
"to",
"Baseline",
",",
"confirmed",
"by",
"colonoscopy",
"during",
"the",
"Screening",
"Period"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02031250 | 1:3:cancer,7:19:cancer,23:44:cancer | T3 or T4 laryngeal or hypopharyngeal cancer that is locally advanced | 3 | [
"T3",
"or",
"T4",
"laryngeal",
"or",
"hypopharyngeal",
"cancer",
"that",
"is",
"locally",
"advanced"
] | [
3,
0,
3,
3,
0,
3,
3,
0,
0,
0,
0
] |
NCT02977299 | ,33:67:treatment, | received at least one dose of a monoamine oxidase inhibitor (MAOI) four weeks or less prior | 3 | [
"received",
"at",
"least",
"one",
"dose",
"of",
"a",
"monoamine",
"oxidase",
"inhibitor",
"(",
"MAOI",
")",
"four",
"weeks",
"or",
"less",
"prior"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02784535 | 20:38:chronic_disease | History of serious neurologic disease | 3 | [
"History",
"of",
"serious",
"neurologic",
"disease"
] | [
0,
0,
0,
2,
2
] |
NCT02589340 | 1:33:chronic_disease | Significant cognitive impairment | 3 | [
"Significant",
"cognitive",
"impairment"
] | [
2,
2,
2
] |
NCT01622868 | ,21:34:cancer,51:71:treatment,75:98:treatment,102:142:treatment,146:181:treatment, | HER2-overexpressing breast cancer (3+ staining by immunohistochemistry or HER2 gene amplification by fluorescent in situ hybridization [FISH] or silver in situ hybridization [SISH] >= 2.0) | 3 | [
"HER2-overexpressing",
"breast",
"cancer",
"(",
"3+",
"staining",
"by",
"immunohistochemistry",
"or",
"HER2",
"gene",
"amplification",
"by",
"fluorescent",
"in",
"situ",
"hybridization",
"[",
"FISH",
"]",
"or",
"silver",
"in",
"situ",
"hybridization",
"[",
"SISH",... | [
1,
1,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02857218 | 15:34:chronic_disease | Patients with renal insufficiency | 3 | [
"Patients",
"with",
"renal",
"insufficiency"
] | [
0,
0,
2,
2
] |
NCT02259504 | 30:36:treatment,38:48:treatment,52:65:treatment | Use of other modified coils (Matrix, HydroCoil® or fibered coils) | 3 | [
"Use",
"of",
"other",
"modified",
"coils",
"(",
"Matrix",
",",
"HydroCoil®",
"or",
"fibered",
"coils",
")"
] | [
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT02098161 | ,,,,180:219:treatment | Pregnant or breast feeding (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive beta-human chorionic gonadotropin (HCG) laboratory test | 3 | [
"Pregnant",
"or",
"breast",
"feeding",
"(",
"lactating",
")",
"women",
",",
"where",
"pregnancy",
"is",
"defined",
"as",
"the",
"state",
"of",
"a",
"female",
"after",
"conception",
"and",
"until",
"the",
"termination",
"of",
"gestation",
",",
"confirmed",
"b... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0
] |
NCT00630565 | 1:29:cancer | Acute myeloid leukemia (AML) | 3 | [
"Acute",
"myeloid",
"leukemia",
"(",
"AML",
")"
] | [
3,
3,
3,
3,
0,
0
] |
NCT02943408 | 1:15:chronic_disease | panic disorder (300.01) | 3 | [
"panic",
"disorder",
"(",
"300.01",
")"
] | [
2,
2,
0,
0,
0
] |
NCT02593526 | 24:43:treatment, | Intention to change to peritoneal dialysis, or home HD in the next 6 months | 3 | [
"Intention",
"to",
"change",
"to",
"peritoneal",
"dialysis",
",",
"or",
"home",
"HD",
"in",
"the",
"next",
"6",
"months"
] | [
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01625234 | 20:68:treatment,70:93:treatment,99:120:treatment | Patients receiving CYP3A substrates with narrow therapeutic indices, strong CYP3A inhibitors, and strong CYP3A inducers | 3 | [
"Patients",
"receiving",
"CYP3A",
"substrates",
"with",
"narrow",
"therapeutic",
"indices",
",",
"strong",
"CYP3A",
"inhibitors",
",",
"and",
"strong",
"CYP3A",
"inducers"
] | [
0,
0,
1,
1,
1,
1,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02058095 | 22:35:chronic_disease,,,,, | Patients with severe liver disease (AST > 3x normal, alkaline phosphatase or bilirubin > 2x normal) | 3 | [
"Patients",
"with",
"severe",
"liver",
"disease",
"(",
"AST",
">",
"3x",
"normal",
",",
"alkaline",
"phosphatase",
"or",
"bilirubin",
">",
"2x",
"normal",
")"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02131467 | 1:10:chronic_disease | hepatitis | 3 | [
"hepatitis"
] | [
2
] |
NCT02500381 | 25:28:chronic_disease | Genotypically confirmed DMD, with genetic deletion amenable to exon 45 or exon 53 skipping | 3 | [
"Genotypically",
"confirmed",
"DMD",
",",
"with",
"genetic",
"deletion",
"amenable",
"to",
"exon",
"45",
"or",
"exon",
"53",
"skipping"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.